Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
F-D-C Reports is a specialized publishing and market intelligence company focused on the pharmaceutical, medical device, and healthcare industries. Founded in 1939 by Wallace Werble, the company became famous for its "color-coded" newsletters, most notably "The Pink Sheet," which provides in-depth coverage of drug regulatory and policy news. Other publications in its portfolio include "The Gray Sheet" for medical devices and "The Rose Sheet" for cosmetics and toiletries. The company's reporting is widely considered the gold standard for tracking FDA activities, legislative changes, and commercial trends affecting the life sciences sector. Over the decades, it has transitioned from a family-owned business to a key component of larger global information providers. After being acquired by Elsevier and later Informa, the F-D-C Reports portfolio is currently managed under the Citeline brand within the Norstella group.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on FDC Reports.